Brachytherapy in the Management of Prostate Cancer

Bradley J. Stish; Brian J. Davis; Lance A. Mynderse; Christopher L. Deufel; Richard Choo

doi:10.1016/j.soc.2017.01.008

Brachytherapy in the Management of Prostate Cancer

Bradley J. Stish, Brian J. Davis, Lance A. Mynderse, Christopher L. Deufel, Richard Choo

Radiation Oncology

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

Brachytherapy is performed by directly inserting radioactive sources into the prostate gland and is an important treatment option for appropriately selected men with prostate adenocarcinoma. Brachytherapy provides highly conformal radiotherapy and delivers tumoricidal doses that exceed those administered with external beam radiation therapy. There is a significant body of literature supporting the excellent long-term oncologic and safety outcomes achieved when brachytherapy is used for men in all risk categories of nonmetastatic prostate cancer. This article highlights some important considerations and published outcomes that relate to brachytherapy and its role in the treatment of prostate cancer.

Original language	English (US)
Pages (from-to)	491-513
Number of pages	23
Journal	Surgical Oncology Clinics of North America
Volume	26
Issue number	3
DOIs	https://doi.org/10.1016/j.soc.2017.01.008
State	Published - Jul 2017

Keywords

Dose escalation
High dose rate brachytherapy
Image guidance
Low dose rate brachytherapy
Prostate cancer
Radiation therapy

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/j.soc.2017.01.008

Cite this

@article{3bd002b6a12044a484d72236476c5dd7,

title = "Brachytherapy in the Management of Prostate Cancer",

abstract = "Brachytherapy is performed by directly inserting radioactive sources into the prostate gland and is an important treatment option for appropriately selected men with prostate adenocarcinoma. Brachytherapy provides highly conformal radiotherapy and delivers tumoricidal doses that exceed those administered with external beam radiation therapy. There is a significant body of literature supporting the excellent long-term oncologic and safety outcomes achieved when brachytherapy is used for men in all risk categories of nonmetastatic prostate cancer. This article highlights some important considerations and published outcomes that relate to brachytherapy and its role in the treatment of prostate cancer.",

keywords = "Dose escalation, High dose rate brachytherapy, Image guidance, Low dose rate brachytherapy, Prostate cancer, Radiation therapy",

author = "Stish, {Bradley J.} and Davis, {Brian J.} and Mynderse, {Lance A.} and Deufel, {Christopher L.} and Richard Choo",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",

year = "2017",

month = jul,

doi = "10.1016/j.soc.2017.01.008",

language = "English (US)",

volume = "26",

pages = "491--513",

journal = "Surgical Oncology Clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Brachytherapy in the Management of Prostate Cancer

AU - Stish, Bradley J.

AU - Davis, Brian J.

AU - Mynderse, Lance A.

AU - Deufel, Christopher L.

AU - Choo, Richard

PY - 2017/7

Y1 - 2017/7

N2 - Brachytherapy is performed by directly inserting radioactive sources into the prostate gland and is an important treatment option for appropriately selected men with prostate adenocarcinoma. Brachytherapy provides highly conformal radiotherapy and delivers tumoricidal doses that exceed those administered with external beam radiation therapy. There is a significant body of literature supporting the excellent long-term oncologic and safety outcomes achieved when brachytherapy is used for men in all risk categories of nonmetastatic prostate cancer. This article highlights some important considerations and published outcomes that relate to brachytherapy and its role in the treatment of prostate cancer.

AB - Brachytherapy is performed by directly inserting radioactive sources into the prostate gland and is an important treatment option for appropriately selected men with prostate adenocarcinoma. Brachytherapy provides highly conformal radiotherapy and delivers tumoricidal doses that exceed those administered with external beam radiation therapy. There is a significant body of literature supporting the excellent long-term oncologic and safety outcomes achieved when brachytherapy is used for men in all risk categories of nonmetastatic prostate cancer. This article highlights some important considerations and published outcomes that relate to brachytherapy and its role in the treatment of prostate cancer.

KW - Dose escalation

KW - High dose rate brachytherapy

KW - Image guidance

KW - Low dose rate brachytherapy

KW - Prostate cancer

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=85020482692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020482692&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2017.01.008

DO - 10.1016/j.soc.2017.01.008

M3 - Review article

C2 - 28576185

AN - SCOPUS:85020482692

SN - 1055-3207

VL - 26

SP - 491

EP - 513

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

IS - 3

ER -

Brachytherapy in the Management of Prostate Cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this